FOLA: Dihydrofolate reductase
Protein in Mycobacterium tuberculosis that 1 drug acts on.
- Drugs that act on it: 1
- Approved: 1
- In phases 1 to 3: 0
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on FOLA, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 1
| Drug | Furthest stage | Sponsor | Modality | Action | Open trials |
|---|---|---|---|---|---|
| Aminosalicylic acid | Approved | Panray | Small molecule | InhibitorDihydrofolate reductase inhibitor | 24 |
| Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel Disease | Aminosalicylic acid | Not applicable | Recruiting | Anabio R&D | Sep 2, 2026 |
| Seaweed Extract (Fucoidan) for Gut Inflammation in Ulcerative Colitis | Aminosalicylic acid | Phase 1 / Phase 2 | Enrolling by invitation | Allama Iqbal Medical College | Aug 26, 2026 |
| Comaprison of Efficacy and Safety Between Etrasimod vs Mesalazine in Chinese Adults With Active UC | Aminosalicylic acid | Phase 4 | Not yet recruiting | Sir Run Run Shaw Hospital | Aug 24, 2026 |
| ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea | Aminosalicylic acid | Early phase 1 | Recruiting | The Second Hospital of Nanjing Medical University | Aug 17, 2026 |
| AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis | Aminosalicylic acid | Not applicable | Not yet recruiting | ENBIOSIS BIOTECHNOLOGIES | Jun 2, 2026 |
| Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis. | Aminosalicylic acid | Not applicable | Recruiting | Qin Yu | Feb 5, 2026 |
| Pentoxifylline in Patients With Ulcerative Colitis | Aminosalicylic acid | Phase 2 | Recruiting | Ihab Elsayed Hassan | Jan 16, 2026 |
| Desloratadine in Patients With Ulcerative Colitis | Aminosalicylic acid | Phase 2 | Recruiting | Tanta University | Jan 12, 2026 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL6065, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-19. ChEMBL and Open Targets